SEC Form 4 · accession 0001206386-18-000012

MYRIAD GENETICS INC · MYGN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — E.V.P., General Counsel

Period of report

Jul 11, 2018

Accepted (ET)

Jul 13, 2018 · 4:19 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000899923

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Jul 11, 2018	M	30,672	$23.11	A	154,869	D
Common Stock	Jul 11, 2018	S	30,672	$44.00	D	124,197	D
Common Stock	Jul 11, 2018	M	40,000	$23.11	A	164,197	D
Common Stock	Jul 11, 2018	S	40,000	$42.0163	D	124,197	D
Common Stock	Jul 11, 2018	G	7,623	$0.00	D	116,574	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Non-Qualified Stock Option (right to buy)	$23.11	Jul 11, 2018	M	30,672	D	Mar 3, 2013	Mar 3, 2020	Common Stock	30,672	40,000	D
Non-Qualified Stock Option (right to buy)	$23.11	Jul 11, 2018	M	40,000	D	Mar 3, 2014	Mar 3, 2020	Common Stock	40,000	0	D